HIV/AIDS

The cost of vaccinating the world against COVID-19 could be at least five times cheaper if pharmaceutical companies weren’t profiteering from their monopolies on COVID-19 vaccines, campaigners from the People’s Vaccine Alliance said today.

According to the World Health Organization, cancer is one of the leading causes of death around the world, with 8.2 million deaths in 2012. In low- and middle-income countries, expensive treatments for cancer are not widely available.

Oxfam today praised the Medicine Patent Pool (MPP) for securing the first licenses for HIV medicines with the pharmaceutical company Gilead, a move that will boost the affordability and eff

Oxfam is shocked and saddened b

Oxfam today welcomed an agreement between the UNITAID-backed Medicine Patent Pool Foundation (MPPF) and the US National Institutes of Health (NIH) to license the antiretroviral drug darunavir to the patent pool. The pool was set up to reduce the cost of HIV medicines.

HIV and AIDS women’s health advocates at the International AIDS Conference have criticized the lack of funding and policy support from international donors and governments for female condoms, which are a critical woman-initiated tool for fighting the HIV epidemic.

As preparations for the world AIDS conference in Vienna get underway, world leaders must take steps to provide immediate access to HIV and AIDS treatment, care and prevention for the millions of poor people who need it.

International agency Oxfam has welcomed the announcement by international drug purchasing agency UNITAID to create a patent pool for HIV drugs. Millions of poor people will now have access to cheaper, more appropriate medicines.

International agency Oxfam today welcomed the prestigious Human Rights Award given to the South African HIV and AIDS organization the Treatment Action Campaign (TAC) by the Friedrich-Ebert-Stiftung/ Foundation.

The European Union is contradicting world trade rules by putting the interests of big drug companies before the 2 billion people in the world who cannot access essential medicines, according to a new report issued today by Oxfam International and Health Action International Europe.